Blog
From the FDA – New Biosimilars Guidance
Blog
Fed. Cir.: Antitrust Issues Can Arise From Hatch-Waxman Litigation
Blog
Ignorance is Bliss – for Teva
Blog
USPTO TRIPs over Myriad-Mayo guidance
Blog
FDA Accepts First Biosimilar Application for Review
Blog
Q. Todd Dickinson Resigns as Executive Director of AIPLA
Blog
Myriad Guidance Comments
Blog
Abbvie V. Janssen Biotech –Written Description Requirement Road Map
Blog
More Questions Than Answers from the PTO
Blog
URGENT – COMMENTS DEADLINE EXTENDED
Blog
USPTO issues post- Alice examination guidelines
Blog